Paeonol protects endotoxin-induced acute kidney injury: Potential mechanism of inhibiting TLR4-NF-κB signal pathway

Oncotarget

Volumn 7, Issue 26, 2016, Pages 39497-39510

  Fan, Hua Ying ^a,b   Qi, Dong ^c   Yu, Chen ^d   Zhao, Feng ^a,b   Liu, Tao ^e   Zhang, Zuo Kai ^a,b   Yang, Ming Yan ^a,b   Zhang, Lei Ming ^a,b   Chen, Da Quan ^a,b   Du, Yuan ^a,b  

^a YANTAI UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c QINGDAO UNIVERSITY   (China)

^d BINZHOU MEDICAL UNIVERSITY   (China)

^e Tai an Central Hospital   (China)

Author keywords

Acute kidney injury; NF B signal pathway; Paeono; Sepsis; TLR4

Indexed keywords

CREATININE; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITROGEN; PEONOL; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UREA; ACETOPHENONE DERIVATIVE; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; RELA PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; CYTOTOXICITY TEST; DISEASE SEVERITY; DNA BINDING; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG STRUCTURE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMICALLY INDUCED; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; KIDNEY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACETOPHENONES; ACUTE KIDNEY INJURY; ANIMALS; BLOOD UREA NITROGEN; CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; KIDNEY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84982921018     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8347     Document Type: Article

References (42)

1. Pickering JW, Endre ZH. The definition and detection of acute kidney injury. J Renal Inj Prev. 2014; 3: 21-25.
2. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, Macleod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007; 18:1292-1298.
3. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294:813-818.
4. Waikar SS, Liu KD, Chertow GM. The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens. 2007; 16:227-236.
5. Wald R, Shariff SZ, Adhikari NK, Bagshaw SM, Burns KE, Friedrich JO, Garg AX, Harel Z, Kitchlu A, Ray JG. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med. 2014; 42:868-877.
6. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359:7-20.
7. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011; 37:241-248.
8. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 2003; 14:1022-1030.
9. Chvojka J, Sykora R, Karvunidis T, Radej J, Krouzecky A, Novak I, Matejovic M. New developments in septic acute kidney injury. Physiol Res. 2010; 59:859-869.
10. Nguyen HB, Smith D. Sepsis in the 21st century: recent definitions and therapeutic advances. Am J Emerg Med. 2007; 25:564-571.
11. Quoilin C, Mouithys-Mickalad A, Duranteau J, Gallez B, Hoebeke M. Endotoxin-induced basal respiration alterations of renal HK-2 cells: a sign of pathologic metabolism down-regulation. Biochem Biophys Res Commun. 2012; 423:350-354.
12. Kaplan J, Nowell M, Chima R, Zingarelli B. Pioglitazone reduces inflammation through inhibition of NF-kappaB in polymicrobial sepsis. Innate Immun. 2013; 20:519-528.
13. Chung HS, Kang M, Cho C, Parvez S, Park CH, Kim D, Oh J, Kim H, Shin M, Hong M, Kim Y, Bae H. Inhibition of nitric oxide and tumor necrosis factor-alpha by moutan cortex in activated mouse peritoneal macrophages. Biol Pharm Bull. 2007; 30:912-916.
14. He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol. 2011; 2:10.
15. Tseng YT, Hsu YY, Shih YT, Lo YC. Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons. Shock. 2012, 37:312-318.
16. Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur J Pharmacol. 2008; 588:124-133.
17. Pan LL, Dai M. Paeonol from Paeonia suffruticosa prevents TNF-alpha-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression. Phytomedicine. 2009; 16:1027-1032.
18. Wang YQ, Dai M, Zhong JC, Yin DK. Paeonol inhibits oxidized low density lipoprotein-induced monocyte adhesion to vascular endothelial cells by inhibiting the mitogen activated protein kinase pathway. Biol Pharm Bull. 2012; 35:767-772.
19. Nizamutdinova IT, Oh HM, Min YN, Park SH, Lee MJ, Kim JS, Yean MH, Kang SS, Kim YS, Chang KC, Kim HJ. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Int Immunopharmacol. 2007; 7:343-350.
20. Hsieh CL, Cheng CY, Tsai TH, Lin IH, Liu CH, Chiang SY, Lin JG, Lao CJ, Tang NY. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. J Ethnopharmacol. 2006; 106:208-215.
21. Pan LL, Dai M. Paeonol from Paeonia suffruticosa prevents TNF-alpha-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression. Phytomedicine. 2009; 16:1027-1032.
22. Chae HS, Kang OH, Lee YS, Choi JG, Oh YC, Jang HJ, Kim MS, Kim JH, Jeong SI, Kwon DY. Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells. Am J Chin Med. 2009; 37:181-194.
23. Chou TC. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J Pharmacol. 2003; 139:1146-1152.
24. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004; 351:159-169.
25. Quoilin C, Mouithys-Mickalad A, Duranteau J, Gallez B, Hoebeke M. Endotoxin-induced basal respiration alterations of renal HK-2 cells: a sign of pathologic metabolism down-regulation. Biochem Biophys Res Commun. 2012; 423:350-354.
26. Schultz MJ, van der Poll T. Animal and human models for sepsis. Ann Med. 2002; 34:573-581.
27. Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest. 2009; 119:2868-2878.
28. Fink MP. Animal models of sepsis. Virulence. 2014; 5:143-153.
29. Tiwari MM, Brock RW, Megyesi JK, Kaushal GP, Mayeux PR. Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol Renal Physiol. 2005; 289:F1324-F1332.
30. Xu D, Chen M, Ren X, Ren X, Wu Y. Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-kappaB signaling pathway. Fitoterapia. 2014; 97:148-155.
31. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008; 109:e102-e107.
32. Rorat M, Jurek T, Simon K. Post-mortem diagnostics in cases of sepsis. Part 2. Biochemical and morphological examinations. Arch Med Sadowej Kryminol. 2015; 65:55-66.
33. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002; 30:S58-S63.
34. Fan X, Liu Z, Jin H, Yan J, Liang HP. Alterations of dendritic cells in sepsis: featured role in immunoparalysis. Biomed Res Int. 2015:903720.
35. Vega-Ramos J, Villadangos JA. Consequences of direct and indirect activation of dendritic cells on antigen presentation: functional implications and clinical considerations. Mol Immunol. 2013; 55:175-178.
36. Frans G, Meyts I, Picard C, Puel A, Zhang SY, Moens L, Wuyts G, Van der Werff TBJ, Casanova JL, Bossuyt X. Addressing diagnostic challenges in primary immunodeficiencies: laboratory evaluation of Toll-like receptor- and NF-kappaB-mediated immune responses. Crit Rev Clin Lab Sci. 2014; 51:112-123.
37. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol. 2008; 8:837-848.
38. Hocherl K, Schmidt C, Kurt B, Bucher M. Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol. 2010; 298:F196-F204.
39. Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. NFkappaB in renal inflammation. J Am Soc Nephrol. 2010; 21:1254-1262.
40. Llona-Minguez S, Baiget J, Mackay SP. Small-molecule inhibitors of IkappaB kinase (IKK) and IKK-related kinases. Pharm Pat Anal. 2013; 2:481-498.
41. Gasparini C, Feldmann M. NF-kappaB as a target for modulating inflammatory responses. Curr Pharm Des. 2012; 18:5735-5745.
42. Lee JE, Kang CS, Guan XY, Kim BT, Kim SH, Lee YM, Moon WS, Kim DK. Discoidin domain receptor 2 is involved in the activation of bone marrow-derived dendritic cells caused by type I collagen. Biochem Biophys Res Commun. 2007; 352:244-250.